Gujarat Themis Biosyn P/E Ratio
Current P/E Ratio
81.34
High Valuation
Very High - High growth expectations or significantly overvalued
Gujarat Themis Biosyn (GUJTHEM) P/E ratio is 81.34 (High), EPS (TTM) ₹4.48, current price ₹389.35 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see GUJTHEM screener.
Current Valuation Metrics
P/E Ratio
81.34
Current Price
₹389.35
EPS (TTM)
₹4.48
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.85
Sector Median
28.95
Sector Rank
#11 of 192
Sector Percentile
5.7%
GUJTHEM P/E Ratio — Valuation Signal & Historical Context
Gujarat Themis Biosyn P/E 81.34 — signal: Overvalued. Browse Gujarat Themis Biosyn financial data for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 81.34, suggesting caution for new investments
- Trading at premium to sector average PE of 49.85
GUJTHEM vs Healthcare Peers — P/E Ratio Comparison
Gujarat Themis Biosyn P/E 81.34 vs Healthcare average 49.85, median 28.95 — range 0.97–869.57.
Sector Average
49.85
Sector Median
28.95
Lowest P/E
0.97
Highest P/E
869.57
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |